{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:34:49Z","timestamp":1791862489644,"version":"4.3.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Describe real-life practice and outcomes in the management of post-stroke upper limb spasticity with botulinum toxin A (BoNT-A) in Asian settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Subgroup analysis of a prospective, observational study (NCT01020500) of adult patients (\u226518\u2009years) with post-stroke upper limb spasticity presenting for routine spasticity management, including treatment with BoNT-A. The primary outcome was goal attainment as assessed using goal-attainment scaling (GAS). Patients baseline clinical characteristics and BoNT-A injection parameters are also described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 51 patients from Asia were enrolled. Rates of comorbid cognitive and emotional problems were relatively low. Patients tended to have more severe distal limb spasticity and to prioritize active over passive function goals. Most (94.1%) patients in the subgroup were treated with abobotulinumtoxinA. For these patients, the median total dose was 500\u2009units, and the most frequently injected muscles were the biceps brachii (83.3%), flexor carpi radialis (72.9%), and flexor digitorum profundus (66.7%). Overall, 74.5% achieved their primary goal and the mean GAS T score after one treatment cycle was 56.0\u2009\u00b1\u200913.0, with a change from baseline of 20.9\u2009\u00b1\u200914.3 (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). The majority (96.1%) of Asian patients were rated as having improved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the Asian treatment setting, BoNT-A demonstrated a clinically significant effect on goal attainment for the real-life management of upper limb spasticity following stroke.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1335365","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T15:02:42Z","timestamp":1712588562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries"],"prefix":"10.3389","volume":"15","author":[{"given":"Raymond L.","family":"Rosales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas V. C.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witsanu","family":"Kumthornthip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khean Jin","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon Soon","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keng He","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Sien","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jeanne","family":"Flordelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard S. W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areerat","family":"Suputtitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/s0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/ene.12062","article-title":"Cost-effectiveness of Onabotulinumtoxina for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in Scotland","volume":"20","author":"Doan","year":"2013","journal-title":"Eur J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/09638288.2016.1198432","article-title":"An international survey of patients living with spasticity","volume":"39","author":"Barnes","year":"2017","journal-title":"Disabil Rehabil"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/09638288.2020.1769207","article-title":"A synthesis and appraisal of clinical practice guidelines, consensus statements and Cochrane systematic reviews for the Management of focal spasticity in adults and children","volume":"44","author":"Williams","year":"2022","journal-title":"Disabil Rehabil"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of Blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development Subcommittee of the American Academy of neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxicon.2012.11.025","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","volume":"67","author":"Esquenazi","year":"2013","journal-title":"Toxicon"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1310\/tsr1601-44","article-title":"Stroke rehabilitation: an international perspective","volume":"16","author":"Teasell","year":"2009","journal-title":"Top Stroke Rehabil"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.11138\/fneur\/2017.32.2.103","article-title":"Ixcellence network\u00ae: an international educational network to improve current practice in the Management of Cervical Dystonia or spastic paresis by botulinum toxin injection","volume":"32","author":"Fheodoroff","year":"2017","journal-title":"Funct Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2340\/16501977-0545","article-title":"Symptomatic upper limb spasticity in patients with chronic stroke attending a rehabilitation clinic: frequency, clinical correlates and predictors","volume":"42","author":"Kong","year":"2010","journal-title":"J Rehabil Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e002771","DOI":"10.1136\/bmjopen-2013-002771","article-title":"Results from the upper limb international spasticity study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin a in real-life clinical management","volume":"3","author":"Turner-Stokes","year":"2013","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1212\/WNL.0b013e31829bfde3","article-title":"Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review","volume":"81","author":"Tsai","year":"2013","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0139461","DOI":"10.1371\/journal.pone.0139461","article-title":"Trends in incidence of stroke and transition of stroke subtypes in rural Tianjin China: a population-based study from 1992 to 2012","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000321734","article-title":"Trends in stroke incidence in Hong Kong differ by stroke subtype","volume":"31","author":"Chau","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1161\/STROKEAHA.107.502807","article-title":"Epidemiological transition of stroke in China","volume":"39","author":"Zhao","year":"2008","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0277296","DOI":"10.1371\/journal.pone.0277296","article-title":"Incidence, subtypes, sex differences and trends of stroke in Taiwan","volume":"17","author":"Tsai","year":"2022","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1161\/STROKEAHA.108.540112","article-title":"Hemorrhagic and ischemic strokes compared","volume":"40","author":"Andersen","year":"2009","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1545968315585357","article-title":"Lesion characteristics of individuals with upper limb spasticity after stroke","volume":"30","author":"Cheung","year":"2016","journal-title":"Neurorehabil Neural Repair"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/09638280400009360","article-title":"The lowest effective dose of botulinum a toxin in adult patients with upper limb spasticity","volume":"27","author":"Suputtitada","year":"2005","journal-title":"Disabil Rehabil"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/toxins10070253","article-title":"Early Abobotulinumtoxina (Dysport((R))) in post-stroke adult upper limb spasticity: ontime pilot study","volume":"10","author":"Rosales","year":"2018","journal-title":"Toxins"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/toxins14110734","article-title":"Abobotulinumtoxina doses in upper and lower limb spasticity: a systematic literature review","volume":"14","author":"Schnitzler","year":"2022","journal-title":"Toxins"},{"key":"ref21","volume-title":"Summary of product information","year":""},{"key":"ref22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/09638288.2013.791727","article-title":"Effectiveness of botulinum toxin injection with and without needle Electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial","volume":"36","author":"Ploumis","year":"2014","journal-title":"Disabil Rehabil"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2014.09.016","article-title":"Can botulinum toxin type a injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques","volume":"347","author":"Santamato","year":"2014","journal-title":"J Neurol Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.23736\/s1973-9087.17.04808-0","article-title":"A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework","volume":"54","author":"Turner-Stokes","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/toxins15120676","article-title":"Selecting goals and target muscles for botulinum toxin a injection using the goal oriented facilitated approach to spasticity treatment (go-fast) tool","volume":"15","author":"Jacinto","year":"2023","journal-title":"Toxins"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2340\/16501977-1817","article-title":"Functional goal achievement in post-stroke spasticity patients: the Botox\u00ae economic spasticity trial (Best)","volume":"46","author":"Ward","year":"2014","journal-title":"J Rehabil Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2340\/16501977-0383","article-title":"Goal attainment scaling: does it provide added value as a person-Centred measure for evaluation of outcome in neurorehabilitation following acquired brain injury?","volume":"41","author":"Turner-Stokes","year":"2009","journal-title":"J Rehabil Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"jrm00157","DOI":"10.2340\/16501977-2801","article-title":"Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin a: findings from the prospective, observational upper limb international spasticity (Ulis-iii) cohort study","volume":"53","author":"Turner-Stokes","year":"2021","journal-title":"J Rehabil Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/jisprm.jisprm_47_19","article-title":"Ulis (upper limb international spasticity), a 10-year odyssey: an international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice","volume":"2","author":"Turner-Stokes","year":"2019","journal-title":"J Int Soc Phys Rehabilit Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/toxins7041192","article-title":"Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin a in real-life clinical practice: sub-analyses from the upper limb international spasticity (Ulis)-ii study","volume":"7","author":"Fheodoroff","year":"2015","journal-title":"Toxins"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1335365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T15:02:48Z","timestamp":1712588568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1335365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":30,"alternative-id":["10.3389\/fneur.2024.1335365"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1335365","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"article-number":"1335365"}}